Regeneron CEO Takes Industry Counterview On FTC Suit: ‘I’m Glad They’re Looking Into This’

 
• By Jessica Merrill

Leonard Schleifer said it is time for US regulators to review whether certain rebate practices are anti-competitive, while speaking at the Financial Times US Pharma & Biotech Summit in response to the FTC’s effort to stop Amgen’s acquisition of Horizon.

New York, NY - June 22, 2022: Dr. Leonard Schleifer attends Governor Kathy Hochul announcement during groundbreaking for Regeneron facilities at company campus in Tarrytown
CEO Leonard Schleifer at a June event on Regeneron's Tarrytown, NY campus • Source: Shutterstock

More from Compliance

More from Pink Sheet